These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23564376)

  • 1. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats.
    Zhao C; Li Y; Qin Y; Wang R; Li G; Sun C; Qu X; Li W
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1541-50. PubMed ID: 23564376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice.
    Thompson BR; Shi J; Zhu HJ; Smith DE
    Biochem Pharmacol; 2020 Oct; 180():114127. PubMed ID: 32603666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2', 2'-difluorodeoxyuridine in rat plasma by UFLC-MS/MS.
    Sun Y; Zhen L; Peng Y; Wang J; Fei F; Aa L; Jiang W; Pei X; Lu L; Liu J; Wang G; Hao K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():4-13. PubMed ID: 29558739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MS.
    Wickremsinhe ER; Lee LB; Schmalz CA; Torchia J; Ruterbories KJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():117-22. PubMed ID: 23831704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive analysis and pharmacokinetic study of a novel gemcitabine carbamate prodrug and its active metabolite gemcitabine in rats using LC-ESI-MS/MS.
    Zhou Y; Chang Q; Wang W; Zhang X; Zhou F; Sun J; Wang G; Peng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():249-257. PubMed ID: 29554521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice.
    Beumer JH; Eiseman JL; Gilbert JA; Holleran JL; Yellow-Duke AE; Clausen DM; D'Argenio DZ; Ames MM; Hershberger PA; Parise RA; Bai L; Covey JM; Egorin MJ
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):421-30. PubMed ID: 20443002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.
    Bangphumi K; Kittiviriyakul C; Towiwat P; Rojsitthisak P; Khemawoot P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):777-785. PubMed ID: 26563392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis.
    Apparaju SK; Gudelsky GA; Desai PB
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):223-9. PubMed ID: 17443325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.
    Beumer JH; Eiseman JL; Parise RA; Joseph E; Covey JM; Egorin MJ
    Clin Cancer Res; 2008 Jun; 14(11):3529-35. PubMed ID: 18519786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
    Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats.
    Chae KA; Cho HJ; Sung JM; Lee H; Seo DC; Kim JS; Shin HC
    J Vet Sci; 2007 Sep; 8(3):263-7. PubMed ID: 17679773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.
    Min R; Li T; Du J; Zhang Y; Guo J; Lu WL
    Can J Physiol Pharmacol; 2008 May; 86(5):288-98. PubMed ID: 18432290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats.
    Lee SD; Lee WI; Shim HJ; Lee ED; Kim WB; Yang J; Kim CK; Lee MG
    J Clin Pharm Ther; 1996 Aug; 21(4):201-13. PubMed ID: 8933293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of a new P-glycoprotein inhibitor HM-30181 in rats using liquid chromatography/electrospray mass spectrometry.
    Paek IB; Ji HY; Kim MS; Lee G; Lee HS
    Rapid Commun Mass Spectrom; 2006; 20(9):1457-62. PubMed ID: 16586459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
    Miao Z; Scott DO; Griffith DA; Day R; Prakash C
    Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.